Does an individual’s sex affect the course of bipolar disorder and schizophrenia?

Schizophrenia and bipolar disorder are serious mental illnesses that affect both males and females, but research in Acta Psychiatrica Scandinavica indicates that sex may influence the characteristics and course of these conditions.

The research included 1,516 individuals from the multicenter PsyCourse Study: 543 with bipolar disorder, 517 with schizophrenia, and 456 healthy controls.

Several differences between groups and sexes were identified in age at diagnosis, age at treatment, illness duration, illicit drug use, and smoking. For example, females in the schizophrenia group were older than males at first outpatient treatment compared with females in the bipolar disorder group. Moreover, those who were older at first outpatient treatment presented a longer duration of illness. Regarding substance use, the highest rates were observed in males with schizophrenia. People with bipolar disorder showed better functioning and neurocognitive performance than those with schizophrenia. Among individuals with bipolar disorder, females reported better performance in verbal memory and psychomotor speed than males. Both females and males with serious mental illnesses showed higher rates of thyroid alterations than healthy controls.

“Our findings reveal a clear message: sex-sensitive treatment is essential for improving clinical outcomes, promoting healthy habits, and managing comorbidities,” said corresponding author Anabel Martinez-Arán, PhD, of the Hospital Clinic of Barcelona.

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1111/acps.70026

Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Acta Psychiatrica Scandinavica is an international forum for the dissemination of information advancing the science and practice of psychiatry. We predominantly focus on clinical psychiatry however with the growing interest of translational psychiatry to our readers, we welcome submission of manuscripts based on both clinical and more translational (e.g. preclinical and epidemiological) research. Publishing highly sought content we’re a 15% ISI-ranked Psychiatry journal with a broad global appeal.

About Wiley
Wiley is a global leader in authoritative content, data-driven insights, and knowledge services that advance science and learning. For more than 200 years, we’ve empowered researchers, learners and institutions worldwide to drive progress and solve the world’s most pressing challenges. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.